Adequacy of family history taking in ovarian cancer patients: a population-based study
暂无分享,去创建一个
L. Kiemeney | L. Massuger | A. V. van Altena | N. Hoogerbrugge | J. D. de Hullu | S. van Aarle | A. van Altena
[1] L. Strong,et al. Clinically relevant changes in family history of cancer over time. , 2011, Journal of the American Medical Association (JAMA).
[2] J. Gohagan,et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.
[3] Barry Rosen,et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. , 2011, Gynecologic oncology.
[4] K. Gelmon,et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial , 2011 .
[5] Mark Robson,et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial , 2010, The Lancet.
[6] A. Tutt,et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial , 2010, The Lancet.
[7] Muin J. Khoury,et al. Family history in public health practice: a genomic tool for disease prevention and health promotion. , 2010, Annual review of public health.
[8] L. Vatten,et al. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population‐based study , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[9] J. Young,et al. Family history? The forgotten question in high‐risk colorectal cancer patients , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[10] S. Gayther,et al. The Contribution of BRCA1 and BRCA2 to Ovarian Cancer , 2009, Molecular oncology.
[11] A. Godwin,et al. Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management , 2009, Molecular oncology.
[12] E. Woodward,et al. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective , 2007, BJOG : an international journal of obstetrics and gynaecology.
[13] P. Krijnen,et al. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data , 2007, Familial Cancer.
[14] F. Couch,et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. , 2006, JAMA.
[15] J. Krischer,et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases , 2005, Cancer.
[16] R. Calderon-Margalit,et al. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature , 2004, International journal of cancer.
[17] H. Murff,et al. Cancer risk assessment: quality and impact of the family history interview. , 2004, American journal of preventive medicine.
[18] H. Murff,et al. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. , 2004, JAMA.
[19] Å. Borg,et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. , 2004, European journal of cancer.
[20] M. King,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.
[21] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[22] Argyrios Ziogas,et al. Validation of family history data in cancer family registries. , 2003, American journal of preventive medicine.
[23] J. Satagopan,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.
[24] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[25] B. Rosen,et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.
[26] D. Evans,et al. The accuracy of diagnoses as reported in families with cancer: a retrospective study , 1999, Journal of medical genetics.
[27] D. Easton,et al. A systematic review and meta‐analysis of family history and risk of ovarian cancer , 1998, British journal of obstetrics and gynaecology.
[28] T. Rebbeck,et al. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. , 1998, American journal of obstetrics and gynecology.